Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1981;59(3):413–425.

Metabolism of 8-aminoquinoline antimalarial agents*

A Strother, I M Fraser, Reza Allahyari, B E Tilton
PMCID: PMC2396074  PMID: 6976849

Abstract

Some of the most effective antimalarial agents are derivatives of 8-aminoquinoline. The metabolic products of many of these compounds appear to be toxic to the erythrocytes of certain human subjects, especially those deficient in glucose-6-phosphate dehydrogenase. Although a number of studies have been conducted over many years, the metabolism of most of these compounds has not been determined. These studies are reviewed.

Adult dogs dosed with tritium-labelled primaquine were observed to excrete approximately 16% of the injected radioactivity in the urine within 8 hours. Organic extracts of the urine were fractionated by thin-layer chromatography and the metabolic pattern obtained. Some primaquine was excreted along with at least five metabolites including 5-hydroxy-6-methoxy-8-(4-amino-1-methylbutylamino)quinoline (5HPQ) and a small amount of 6-hydroxy-8-(4-amino-1-methylbutylamino)quinoline (6HPQ). The 5HPQ could form a quinoneimine-type compound which may be a methaemoglobin-forming compound. This and other metabolites isolated from urine were found to be active methaemoglobin formers in in vitro studies. In vitro metabolism of primaquine by mouse liver enzymes also produced compounds capable of methaemoglobin formation. One of these had a blue colour when exposed to alkaline conditions, air, and light, and mass spectral data and nuclear magnetic resonance analysis indicated a structure similar to a 5,6-dihydroxy derivative of primaquine. However, the chemical structure of the metabolite was not identified in these studies.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fraser I. M., Vesell E. S. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. J Pharmacol Exp Ther. 1968 Jul;162(1):155–165. [PubMed] [Google Scholar]
  2. Hewick D. S., Fouts J. R. Effects of storage on hepatic microsomal cytochromes and substrate-induced difference spectra. Biochem Pharmacol. 1970 Feb;19(2):457–472. doi: 10.1016/0006-2952(70)90201-7. [DOI] [PubMed] [Google Scholar]
  3. ROBIN H., HARLEY J. D. PRACTICAL APPLICATIONS OF THE SIMULTANEOUS DETERMINATION OF OXYHAEMOGLOBIN AND METHAEMOGLOBIN CONCENTRATIONS. Australas Ann Med. 1964 Nov;13:313–319. doi: 10.1111/imj.1964.13.4.313. [DOI] [PubMed] [Google Scholar]
  4. SAX S. M., LYNCH H. J. OXIDATION OF QUINOLINE BY RABBIT LIVER. J Pharmacol Exp Ther. 1964 Jul;145:113–121. [PubMed] [Google Scholar]
  5. SMITH J. N., WILLIAMS R. T. Studies in detoxication. 65. The metabolism of quinoline; new metabolites of quinoline, with observations on the metabolism of 3-, 5- and 6-hydroxyquinoline and 2:4-dihydroxyquinoline. Biochem J. 1955 Jun;60(2):284–290. doi: 10.1042/bj0600284. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES